Cognitive profile of LRRK2 -related Parkinson's disease-Reference-Cited by-同舟云学术

Cognitive profile of LRRK2 -related Parkinson's disease

Published:2015-02-04 Issue:5 Volume:30 Page:728-733
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Srivatsal Sindhu¹,Cholerton Brenna²³,Leverenz James B.⁴,Wszolek Zbigniew K.⁵,Uitti Ryan J.⁵,Dickson Dennis W.⁵,Weintraub Daniel⁶⁷⁸,Trojanowski John Q.⁹¹⁰,Van Deerlin Vivianna M.⁹,Quinn Joseph F.¹¹¹²,Chung Kathryn A.¹¹¹²,Peterson Amie L.¹¹¹²,Factor Stewart A.¹³,Wood-Siverio Cathy¹³,Goldman Jennifer G.¹⁴,Stebbins Glenn T.¹⁴,Bernard Bryan¹⁴,Ritz Beate¹⁵¹⁶¹⁷,Rausch Rebecca¹⁷,Espay Alberto J.¹⁸,Revilla Fredy J.¹⁸,Devoto Johnna¹⁸,Rosenthal Liana S.¹⁹,Dawson Ted M.¹⁹²⁰²¹,Albert Marilyn S.¹⁹,Mata Ignacio F.²,Hu Shu-Ching²²²,Montine Kathleen S.²³,Johnson Catherine²⁴,Montine Thomas J.²³,Edwards Karen L.²⁴,Zhang Jing²³,Zabetian Cyrus P.²²²

Affiliation:

1. Virginia Mason Neuroscience Institute; Seattle Washington USA

2. Veterans Affairs Puget Sound Health Care System; Seattle Washington USA

3. Department of Psychiatry and Behavioral Sciences; University of Washington School of Medicine; Seattle Washington USA

4. Lou Ruvo Center for Brain Health, Neurological Institute; Cleveland Clinic Cleveland Ohio USA

5. Department of Neurology; Mayo Clinic; Jacksonville Florida USA

6. Department of Neurology; University of Pennsylvania; Philadelphia Pennsylvania USA

7. Department of Psychiatry; University of Pennsylvania; Philadelphia Pennsylvania USA

8. Philadelphia Veterans Affairs Medical Center; Philadelphia Pennsylvania USA

9. Department of Pathology and Laboratory Medicine; University of Pennsylvania; Philadelphia Pennsylvania USA

10. Institute on Aging, University of Pennsylvania; Philadelphia Pennsylvania USA

11. Portland Veterans Affairs Medical Center; Portland Oregon USA

12. Department of Neurology; Oregon Health and Science University; Portland Oregon USA

13. Department of Neurology; Emory University School of Medicine; Atlanta Georgia USA

14. Department of Neurological Sciences; Rush University Medical Center; Chicago Illinois USA

15. Department of Epidemiology; School of Public Health, University of California Los Angeles; Los Angeles California USA

16. Department of Environmental Health Sciences; School of Public Health, University of California Los Angeles; Los Angeles California USA

17. Department of Neurology; School of Medicine, University of California Los Angeles; Los Angeles California USA

18. Department of Neurology and Rehabilitation Medicine; University of Cincinnati; Cincinnati Ohio USA

19. Department of Neurology; Johns Hopkins University School of Medicine; Baltimore Maryland USA

20. Neuroregeneration and Stem Cell Programs; Institute for Cell Engineering, Johns Hopkins University School of Medicine; Baltimore Maryland USA

21. Solomon H. Snyder Department of Neuroscience; Johns Hopkins University School of Medicine; Baltimore Maryland USA

22. Department of Neurology; University of Washington School of Medicine; Seattle Washington USA

23. Department of Pathology; University of Washington School of Medicine; Seattle Washington USA

24. Department of Epidemiology; School of Medicine, University of California Irvine; California USA

Funder

National Institutes of Health

U.S. Department of Veterans Affairs Merit Award

Parkinson's Disease Foundation, the Nancy and Buster Alvord Endowment

Jane and Lee Seidman Fund

Consolidated Anti-Aging Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.26161/fullpdf

Reference37 articles.

1. The rate of cognitive decline in Parkinson disease;Aarsland;Arch Neurol,2004

2. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia;Janvin;Mov Disord,2006

3. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study;Alcalay;Neurology,2012

4. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations;Chahine;JAMA Neurol,2013

5. Variations in APOE, but not MAPT or SNCA, predicts cognitive performance in Parkinson's disease;Mata;JAMA Neurol,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomics and weighted protein network analyses of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson’s Disease;npj Parkinson's Disease;2024-08-03

2. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort;CNS Neuroscience & Therapeutics;2024-08

3. The Parkinson's Disease Composite of Executive Functioning;Neurology;2024-07-23

4. Pathogenic LRRK2 causes age-dependent and region-specific deficits in ciliation, innervation and viability of cholinergic neurons;2024-07-18

5. Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine;Frontiers in Aging Neuroscience;2024-07-04